CN Stock MarketDetailed Quotes

688428 InnoCare Pharma

Watchlist
  • 12.10
  • -0.23-1.87%
Market Closed Dec 25 15:00 CST
21.33BMarket Cap-56.81P/E (TTM)

InnoCare Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InnoCare Pharma FY2024 9-Month Earnings Date

Currency：CNYNov 11, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
697.75M
--
+29.85%
EPS
--
-0.16
--
+48.39%
Analyst Rating
Buy

Dec 25, 2024

InnoCare Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 275.813M--
--2024/Q4-- / 310.303M--
--2024/Q3278.010M / 288.000M--
--2024/Q2251.176M / 196.275M--
May 14, 20242024/Q1165.824M / 181.644M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 275.813M--
--2024/Q4-- / 310.303M--
--2024/Q3278.010M / 288.000M--
--2024/Q2251.176M / 196.275M--
May 14, 20242024/Q1165.824M / 181.644M--

Unlock Free Earnings Estimates

InnoCare Pharma Earnings Reports

  • Nuochengjianhua Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Nov 11 11:00 ET

  • InnoCare Pharma: Announcement of midterm performance for the six months ending on June 30, 2024.

    Aug 20 12:00 ET

  • Innocare Pharmaceutical Co., Ltd. Summary of 2024 Interim Report

    Aug 20 12:00 ET

  • Innocare Pharmaceuticals Co., Ltd. 2024 Half-year Report

    Aug 20 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 25, 2024

    Buy

    • Strong Buy

      50.00%

    • Buy

      37.50%

    • Hold

      12.50%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme AH Stocks
    AH Stocks
    Intraday+0.71%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday-0.19%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-0.19%